The Joint and the Marketing that Turns Wellness into Habit
The financial picture of The Joint Corp. in 2025 appears contradictory at first glance. Its #F5F5F5]">revenue increased to $54.9 million from $52.2 million in 2024, and it transitioned from a net loss of $5.8 million to a net gain of $2.9 million. It also raised its adjusted EBITDA to $13.0 million, a 13.9% increase. However, the business pulse of the system does not follow with the same clarity: system sales (what all clinics bill, not what comes in as corporate accounting revenue) barely grew by 0.4% and comparable sales fell by 0.4% for the year and 3.8% in the fourth quarter. Nevertheless, the company increased expenditure on sales and marketing by 25.2% to $3.5 million, attributed to a shift towards national marketing. All of this was reported on March 12, 2026, via GlobeNewswire. [https://www.benzinga.com/pressreleases/26/03/g51226729/the-joint-corp-reports-2025-fourth-quarter-and-full-year-financial-results
When a company improves profitability with negative comparable sales, a useful analysis for a marketing leader is not to celebrate efficiency without nuance. It's to read the operational pattern: The Joint is pushing a transformation (“Joint 2.0”) to become nearly a pure franchisor, refranchaing 41 clinics in 2025, with 27 more in process, and reducing exposure to owned or managed clinics. It closed the year with 960 clinics (885 franchised and 75 owned/managed), down from 967 in 2024, with 29 openings and 36 closures. Meanwhile, it bought back 1.3 million shares for $11.3 million and ended with $23.6 million of unrestricted cash, plus an undrawn credit line of $20 million until 2027. This context matters because it defines the type of marketing that becomes rational: less marketing “to tell a story” and more marketing to sustain a motor of repeat visits and resilient royalties.
When Marketing Increases but Comparables Decline
The uncomfortable data is out in the open: in the fourth quarter, system sales fell by 3.9% and comparable sales fell by 3.8%, while spending on sales and marketing rose by 25.2%. It would be easy to label this as inefficiency; it would be a hasty mistake. The correct reading depends on what the company was buying with that expenditure.
The Joint attributes the increase to a turn towards national marketing. This type of investment rarely translates into immediate response within the same quarter, especially in services where consumption is tied to pain, stress, routine, and discretionary budget. In a franchise model, corporate marketing also serves a secondary but critical function: it standardizes demand and reduces volatility between locations, which improves the health of the system and, by extension, the ability to sell licenses. Here, another signal emerges: the company sold 31 franchise licenses in 2025, fewer than the 46 sold in 2024. With fewer licenses sold and unit closures, national marketing may be functioning as a stabilizer of the main asset, which is not the owned clinic, but the perception that “opening a Joint” brings traffic.
Still, marketing is not measured by intention, but by its operational effect. If the system closed with 14.4 million visits (vs. 14.7 million in 2024), the challenge is concrete: to sustain repeat visits in a category where many consumers “come in for pain” and “leave when they feel better.” In that journey, marketing becomes the bridge between an episodic service and a habit. If the bridge fails, comparable sales decline even if the company cuts costs or refranchises.
The consequence for marketing is that the objective cannot simply be acquisition. In service clinics, a national campaign that does not reduce attrition and does not push frequency ends up inflating the system's CAC and putting pressure on the franchisee, even though the corporate entity shows better EBITDA due to a leaner structure.
The Franchise as Product and the Consumer as Arbiter
The shift towards a pure franchisor is, financially, a disciplined play: fewer operational assets, lower direct costs, more revenue from royalties and fees, and a margin profile that tends to withstand better when consumption cools. The company itself highlights advancements in this direction and its progress toward being a “pure-play franchisor.” That transition shows in numbers: from 125 owned/managed clinics in 2024, it dropped to 75 in 2025, aiming to continue decreasing.
From a marketing perspective, this change alters who the immediate “customer” of the corporation is. The patient does not disappear, but the franchisee emerges strongly as a buyer of a package: brand, demand generation, operational learnings, and probable unit economics. When the company refranchises 41 clinics and has 27 in process, it is rewriting its promise to the franchisee: less risk of centralized operation, more consistency, and support.
The problem is that this support is validated where it hurts the most: in comparable sales and visit frequency. In 2025, the system saw almost no growth in sales and a decline in visits. This does not invalidate the franchise model, but it does require that marketing be less about “media” and more about “mechanics”: improving local conversion, reducing drop-off, and accelerating the breakeven point for openings. The company claims progress such as “lower attrition” and “faster breakeven” in new openings, even “half the previous time,” but does not provide specific figures in the source. In the absence of those details, executive prudence is to assume that the effect exists but is uneven: some clinics are likely improving their curve; others are being closed due to underperformance.
The key is to recognize that in frictionless wellness services without insurance, the consumer acts as a weekly arbiter, not an annual one. If the proposition is not comfortable, predictable, and easy to repeat, the patient does not return. The franchisee sees this in cash flow before anyone else. Therefore, in a capital-light model, corporate marketing is an operational promise: it buys demand consistency so that the system is not fractured by disparate results.
What the Decline in Visits Reveals about User “Work”
The 14.4 million visits in 2025 are huge in absolute terms, but the decrease compared to 2024 matters for what it hints about behavior. Retail-format chiropractic has an obvious advantage: it reduces barriers, simplifies access, and can normalize care as routine. However, that same accessibility competes with a reality: the consumer does not wake up wanting “chiropractic services”; they want to keep functioning with less pain, more mobility, or more energy. When that is achieved, the service runs the risk of becoming “mission accomplished” and disappearing from the calendar.
This is where national marketing can be both a success and a distraction. Success, if it turns a corrective service into a maintenance ritual, with brand recall and a simple narrative that makes returning feel logical. Distraction, if it is used as a band-aid for a proposition that is not generating enough local repeat. The negative comparable data suggests that, at least in the short term, the system is facing friction in that transition from “I tried” to “I stay.”
It is also worth looking at the fourth quarter: corporate revenue of $15.2 million (+3.1%), adjusted EBITDA of $3.6 million (+7.8%) and cost of revenue down 11.5% to $2.8 million. This indicates financial execution. However, system demand fell. When this happens, the typical risk in franchises is divergence: the corporation celebrates margin; some franchisees feel stagnation. In the medium term, that divergence impacts net openings and license sales, just an indicator that has already dropped.
The marketing that a system like this needs is not just more reach. It’s a repetition architecture: communication that pushes frequency, digital assets that capture local intent (the company mentions improved site search authority), and messages that connect with the progress the user is “hiring.” If the progress is “continue performing without losing a day to pain,” the system must design reminders, memberships, and consistent experiences that transform momentary relief into continuity.
The 2026 Guidance Limits Room for Marketing Errors
The company projects for 2026 system sales between $519 million and $552 million, comparables between -3% and 3%, and adjusted EBITDA between $12.5 million and $13.5 million, along with 30 to 35 franchised openings (excluding refranchising) and the possibility of additional closures of weak-performing units. That range is an admission of business uncertainty: the engine can be maintained, but recovery of comparables is not guaranteed.
For marketing, that guidance narrows the margin for maneuver for two reasons. First, when the financial objective is to maintain EBITDA within a relatively stable range, marketing spending becomes scrutinized with a return logic, not experimentation. Second, if there will be closures of weak units, the brand faces a geographical problem: every closure opens up a convenience gap, and in service retail, convenience is part of the product.
At the same time, The Joint retains financial flexibility: $23.6 million of unrestricted cash, an unused credit line of $20 million, and a buyback program with $5.7 million remaining. This is a balance that allows maintaining investment in the brand, but the buyback also reveals a priority: return to shareholders while stabilizing the system. In that context, marketing must justify its role as a stabilizer of the franchise asset.
Operationally, the most sensible path to capture the high end of the guidance does not depend on inventing new messages but on polishing repeatable mechanics that reduce drop-off and accelerate the breakeven point of new clinics. The company is already attempting this with a pivot to national marketing and digital improvements, according to its statement. The test will be whether comparables stop falling without the need to increase spending at a pace that jeopardizes EBITDA.
The takeaway for any retail health service brand is clear: when the business transitions to franchise, marketing ceases to be a “brand” cost center and becomes the infrastructure of the system. If that infrastructure does not convert visits into habits, expansion becomes fragile even if the corporate entity looks leaner.
Habit is the Product the Consumer is Purchasing
The performance of The Joint in 2025 showcases a company that improved profitability with a lighter structure, but with signs of pressure on repeat visits. The consumer behavior that dictates this is straightforward: the user hires this type of service to keep functioning with less physical friction, and the business innovation consists of converting that relief into a sustainable routine, not an isolated visit.
